Literature DB >> 16823936

New method for obtaining conjugated vaccines.

Osmir Cabrera1, Maribel Cuello, Carmen R Soto, Miguel E Martínez, Judith M del Campo, Oliver a Pérez, Juan F Infante, Gustavo Sierra.   

Abstract

We describe a new method to obtain conjugates against Neisseria meningitidis serogroups A, B, C, Vibrio cholera, and Salmonella typhi and their immunogenicity in Balb/c mice. The saccharides were activated by basic hydrolysis with the generation of amine groups in the saccharidic chain, and these groups were linked to carboxyl groups of tetanus toxoid by via carbodiimida-mediated reaction. The resultant conjugates were administered to mice for the immunogenicity studies. The pirogenicity of LPS was measured by LAL assay. The anti-saccharide IgG, IgG1, and IgG2a antibodies were evaluated. A significant decrease in the pirogenicity of LPS after basic hydrolysis treatment was observed. The conjugates elicited higher titers of anti-polysaccharides or anti-LPS IgG, IgG1, and IgG2a in conjugates than in unconjugated saccharides. The results indicate that we have a new method for obtaining conjugated vaccines and we have demonstrated that after conjugation there was a change in the responses for all saccharides, from thymus-independent to thymus-dependent responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823936     DOI: 10.1016/j.vaccine.2005.01.131

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba.

Authors:  Cyrille Grandjean; Alain Boutonnier; Bruno Dassy; Jean-Michel Fournier; Laurence A Mulard
Journal:  Glycoconj J       Date:  2008-07-23       Impact factor: 2.916

2.  Preparation and Evaluation of a New Lipopolysaccharide-based Conjugate as a Vaccine Candidate for Brucellosis.

Authors:  Seyed Davar Siadat; Farzam Vaziri; Mamak Eftekhary; Maryam Karbasian; Arfa Moshiri; Mohammad R Aghasadeghi; Mehdi S Ardestani; Meghdad Abdollahpour Alitappeh; Amin Arsang; Abolfazl Fateh; Shahin Najar Peerayeh; Ahmad R Bahrmand
Journal:  Osong Public Health Res Perspect       Date:  2014-12-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.